Newer antibacterial drugs for a new century

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Expert Opinion on Investigational Drugs

• Publication date

  2010-01-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1517/13543780903505092PMID 20053150PMCID PMC2831224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II

  2009cited by this paper
• Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.

  2009cited by this paper
• Efficacy of Aerosol MP-376, a Levofloxacin Inhalation Solution, in Models of Mouse Lung Infection Due to Pseudomonas aeruginosa

  2009cited by this paper
• Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

  2009cited by this paper
• Comparative in vitro activity of oritavancin against Staphylococcus aureus strains that are resistant, intermediate or heteroresistant to vancomycin.

  2009cited by this paper
• Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infections

  2009cited by this paper
• In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent

  2009cited by this paper
• Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin.

  2009cited by this paper
• Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity.

  2009cited by this paper
• The diarylquinoline TMC207 for multidrug-resistant tuberculosis.

  2009cited by this paper
• Activity of the anti-MRSA carbapenem razupenem (PTZ601) against Enterobacteriaceae with defined resistance mechanisms.

  2009cited by this paper
• In Vitro Activity of NXL104 in Combination with β-Lactams against Klebsiella pneumoniae Isolates Producing KPC Carbapenemases

  2009influential reference
• Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.

  2009cited by this paper
• Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.

  2009cited by this paper
• Helicobacter Pylori associated global gastric cancer burden.

  2009cited by this paper
• P1A Recombinant β-Lactamase Prevents Emergence of Antimicrobial Resistance in Gut Microflora of Healthy Subjects during Intravenous Administration of Ampicillin

  2009cited by this paper
• Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance.

  2009cited by this paper
• In Vitro Activity of Ceftaroline Alone and in Combination against Clinical Isolates of Resistant Gram-Negative Pathogens, Including β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa

  2009cited by this paper
• Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections

  2009cited by this paper
• In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Microbiology Profiling Studies with Staphylococci and Streptococci

  2008cited by this paper
• Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and Pseudomonas aeruginosa

  2008cited by this paper
• In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains

  2008cited by this paper
• In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Studies of the Mode of Action in Staphylococcus aureus

  2008cited by this paper
• Novel beta-lactam antibiotics and inhibitor combinations.

  2008influential reference
• Desperately Seeking New Antibiotics

  2008cited by this paper
• Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.

  2008cited by this paper
• A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence

  2008cited by this paper
• Cell-division inhibitors: new insights for future antibiotics

  2008cited by this paper
• An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity

  2008cited by this paper
• Physicochemical properties of antibacterial compounds: implications for drug discovery.

  2008cited by this paper
• Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.

  2008influential reference
• Neospora caninum: functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides.

  2008cited by this paper
• A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.

  2008cited by this paper
• A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.

  2008cited by this paper
• Antivirulence as a new antibacterial approach for chemotherapy.

  2008cited by this paper
• The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis

  2008cited by this paper
• Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis

  2008cited by this paper
• In Vitro Activity of Ceftobiprole against Pathogens from Two Phase 3 Clinical Trials of Complicated Skin and Skin Structure Infections

  2008cited by this paper
• Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study.

  2008cited by this paper
• Targeting QseC Signaling and Virulence for Antibiotic Development

  2008cited by this paper
• In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria

  2008cited by this paper
• Telithromycin and the FDA: implications for the future.

  2008cited by this paper
• Oritavancin in the Treatment of Complicated Skin and Skin Structure Infections (cSSSI): Combined Results of Two Phase 3 Multinational Trials

  2008cited by this paper
• A Comparative Study of the Safety and Efficacy of Cethromycin (CER) to Clarithromycin (CLR) for the Treatment of Community Acquired Pneumonia (CAP) in Adults (CL05-001)

  2008cited by this paper
• Telavancin for Hospital-Acquired Pneumonia Caused by S. aureus : Efficacy Analysis According to the In Vitro Susceptibility to Vancomycin

  2008cited by this paper
• In Vitro Time Kill Studies of Oritavancin Against Vancomycin-Intermediate Staphylococcus aureus (VISA)

  2008cited by this paper
• A Phase 2 Study Comparing Two Doses of Radezolid to Linezolid in Adults with Uncomplicated Skin and Skin Structure Infections (uSSSI)

  2008cited by this paper
• Multicenter Evaluation of In Vitro Activity of Tigecycline Against Carbapenemase Producing Gram Negative Isolates from Colombia

  2008influential reference
• CANVAS-1: Randomized, Double-blinded, Phase 3 Study (P903-06) of the Efficacy and Safety of Ceftaroline vs. Vancomycin plus Aztreonam in Complicated Skin and Skin Structure Infections (cSSSI)

  2008cited by this paper
• Telavancin for Treatment of Hospital-Acquired Pneumonia (HAP) Caused by MRSA and MSSA: The ATTAIN Studies

  2008cited by this paper
• Novel β-lactam antibiotics and inhibitor combinations

  2008cited by this paper
• Bacteriophage Therapy in a Mouse Model of Burkholderia Infection

  2008cited by this paper
• AM-3005: Synthesis and In Vitro Antibacterial Activity of Novel Mutilin-Quinolone Hybrid Antibacterial Agent

  2008cited by this paper
• In Vitro Antibacterial Activity of Sulopenem: A New Oral Penem Antimicrobial Versus Recent Bacterial Clinical Isolates

  2008cited by this paper
• Characterization of Resistance to Doripenem, Meropenem and Imipenem in Pseudomonas aeruginosa

  2008cited by this paper
• In Vitro Activities of Piperacillin in Combination with BLI-489 and Comparative Antibacterial Agents Against Recent Clinical Isolates

  2008cited by this paper
• In Vitro Activity of the Siderophore Monobactam BAL30072 against Multi-resistant Non-fermenting Gram-negative Pathogens

  2008cited by this paper
• Broad Spectrum In Vitro Activity of JNJ-Q2, a New Fluoroquinolone

  2008cited by this paper
• Efficacy of BAL30376, a New Monobactam/ beta-Lactamase Inhibitor Combination, against Pseudomonas aeruginosa (PA)

  2008cited by this paper
• In Vitro Activity of Oritavancin against CA-MRSA, VISA and Daptomycin-non-susceptible Staphylococcus aureus (DNSSA )

  2008cited by this paper
• Effect of pH on the In Vitro Activity of Finafloxacin against Gram-negative and Gram-positive Bacteria

  2008cited by this paper
• Binding of Ceftaroline (CPT) to Penicillin-Binding Proteins (PBPs) of Streptococcus pneumoniae (SPN) and Methicillin-Resistant Staphylococcus aureus (MRSA)

  2008cited by this paper
• Are Natural Products Still a Viable Source for New Antimicrobial Agents

  2008cited by this paper
• Design, Synthesis and Antibacterial properties of new potent Aryloxy-phenol FabI Inhibitors

  2008cited by this paper
• Novel DNA Gyrase Inhibitors: Structure-guided Discovery and Optimization of Pyrrolamides

  2008cited by this paper
• In Vivo Efficacy of Novel Prodrugs of Sulopenem

  2008cited by this paper
• Clinical Efficacy of Iclaprim in Complicated Skin and Skin Structure Infection (cSSSI): Results of Combined ASSIST Phase III Studies

  2008cited by this paper
• MUT37307 A Novel Antibacterial Against Methicillin Resistant Staphylococci

  2008cited by this paper
• How Can We Improve our Anti-Infective Compound Libraries?

  2008cited by this paper
• A nuclear receptor-like pathway regulating multidrug resistance in fungi

  2008cited by this paper
• Efficacy and safety of intravenous infusion of doripenem versus imipenem in ventilator-associated pneumonia: A multicenter, randomized study*

  2008cited by this paper
• Oritavancin exhibits dual mode of action to inhibit cell-wall biosynthesis in Staphylococcus aureus.

  2008cited by this paper
• Selection for High-Level Telithromycin Resistance in Staphylococcus aureus Yields Mutants Resulting from an rplB-to-rplV Gene Conversion-Like Event

  2008cited by this paper
• Clinical Outcomes, Safety, and Pharmacokinetics of OPT-80 in a Phase 2 Trial with Patients with Clostridium difficile Infection

  2008cited by this paper
• Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics.

  2008cited by this paper
• Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia.

  2008cited by this paper
• Carbapenemases: the versatile beta-lactamases.

  2007influential reference
• Targeting virulence: a new paradigm for antimicrobial therapy

  2007cited by this paper
• A Novel Giardia lamblia Nitroreductase, GlNR1, Interacts with Nitazoxanide and Other Thiazolides

  2007cited by this paper
• In Vitro Activity of the Oxazolidinone RWJ-416457 against Linezolid-Resistant and -Susceptible Staphylococci and Enterococci

  2007cited by this paper
• Telithromycin Resistance in Streptococcus pneumoniae Is Conferred by a Deletion in the Leader Sequence of erm(B) That Increases rRNA Methylation

  2007cited by this paper
• Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1

  2007cited by this paper
• Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria

  2007cited by this paper
• Drugs for bad bugs: confronting the challenges of antibacterial discovery

  2007cited by this paper
• The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria.

  2007cited by this paper
• Carbapenemases: the Versatile β-Lactamases

  2007cited by this paper
• New oxazolidinones.

  2007cited by this paper
• Emerging bacterial enzyme targets.

  2007cited by this paper
• Will longer antimicrobial patents improve global public health?

  2007influential reference
• The oxazolidinone class of drugs find their orientation on the ribosome.

  2007cited by this paper
• Bactericidal Activity and Resistance Development Profiling of Dalbavancin

  2007cited by this paper
• Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli

  2007cited by this paper
• Salicylidene Acylhydrazides That Affect Type III Protein Secretion in Salmonella enterica Serovar Typhimurium

  2007cited by this paper
• Interactions of ceftobiprole with beta-lactamases from molecular classes A to D.

  2007cited by this paper
• Interactions of Ceftobiprole with β-Lactamases from Molecular Classes A to D

  2007cited by this paper
• Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial.

  2006cited by this paper
• Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus.

  2006cited by this paper
• Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

  2006cited by this paper
• The highly conserved LepA is a ribosomal elongation factor that back-translocates the ribosome.

  2006cited by this paper
• Anti-infective antibodies: finding the path forward

  2006cited by this paper

• Ethanolic extracts from deep marine sponges: A new frontier in antibacterial discovery from the Jordanian Gulf of Aqaba.

  2026cites this paper
• Synthesis and biological activity evaluation of a novel pleuromutilin derivative 22-((2-methyl-1-(1H-pyrrole-2-carboxamido)propan-2-yl)thio)-deoxypleuromutilin

  2025cites this paper
• Iron(II) Chloride Catalyzed Ligand-Free Double Carbonylation of o-Diiodoarenes with Anilines: A Novel Synthetic Approach to Phthalimide Derivatives

  2025cites this paper
• Coculturing Streptomyces sp. with Acanthamoeba polyphaga enhances the antimicrobial effectiveness of its crude extract against multidrug-resistant Pseudomonas aeruginosa and Escherichia coli.

  2025cites this paper
• Selective Targeting and Enhanced Photodynamic Inactivation of Methicillin-Resistant Staphylococcus aureus (MRSA) by a Decacationic Vancomycin–Mesochlorin Conjugate

  2025cites this paper
• Design, synthesis, and bioactivity of newly potent pleuromutilin derivatives.

  2025cites this paper
• Imidazole‐Oxadiazole Hybrid as Potential Antimicrobial Agents: Design, Synthesis, Drug–Likeness, Pharmacophore and Molecular Docking Study

  2024cites this paper
• Synthesis, molecular docking study, and biological evaluation and of new thiadiazole and thiazole derivatives incorporating isoindoline-1,3-dione moiety as anticancer and antimicrobial agents

  2024cites this paper
• Nanometal surface energy transfer (NSET) from biologically active heterocyclic ligands to silver nanoparticles induces enhanced antimicrobial activity against gram-positive bacteria.

  2024cites this paper
• Global research trends in therapeutic drug monitoring of antimicrobials from 2000 to 2023: a bibliometric analysis

  2024cites this paper
• Multi-Faceted Exploration of Amide-Amine Tethered 1,2,3-Triazole Conjugates as antimicrobial agents using synthetic, in vitro and in silico approach

  2024cites this paper
• The effect of novel antimicrobial agents on the normal functioning of human intestinal microbiota: a systematic review

  2023cites this paper
• Nanotheranostics to Target Antibiotic-resistant Bacteria: Strategies and Applications

  2023cites this paper
• Antimicrobial Efficacy of Argon Cold Atmospheric Pressure Plasma Jet on Clinical Isolates of Multidrug-Resistant ESKAPE Bacteria

  2023cites this paper
• From The Germ Theory to Antimicrobials and Antibiotic Resistance

  2023cites this paper
• Design and synthesis of chalcone mediated novel pyrazoline scaffolds: Discovery of benzothiophene comprising antimicrobial inhibitors

  2023cites this paper
• Prevalence and Outcomes of Carbapenem-resistant Bloodstream Infection in Children With Cancer

  2023cites this paper
• Antimicrobial Resistance and Its Drivers—A Review

  2022cites this paper
• Multi-drug Resistant Organisms in Stool Culture and Its Relationship with Morbidity and Mortality in Pediatric Patients with Acute Leukemia

  2022cites this paper
• Antimicrobial and anticancer activities of Periplaneta americana tissue lysate: An in vitro study

  2022cites this paper
• Antibacterial, Antioxidant and DNA Cleavage Activity Evaluation of Substituted Phenylureido Sulfaguanidine and Sulfamethazine Derivatives

  2022cites this paper
• Investigation of radezolid interaction with non-canonical chloramphenicol binding site by molecular dynamics simulations.

  2021cites this paper
• Shortening Synthetic Routes to Small Molecule Active Pharmaceutical Ingredients Employing Biocatalytic Methods.

  2021cites this paper
• 3-(1,3-Dioxoisoindolin-2-yl)-N,N-dimethylpropan-1-ammonium perchlorate: Synthesis, crystal structure, docking study and in vitro anticancer activity against the human hepatomas cell line (Hep G2)

  2021cites this paper
• Peptides as therapeutic molecules to neutralize Gram-negative bacterial lipopolysaccharides in sepsis and septic shock.

  2021cites this paper
• Nanozyme Applications: A Glimpse of Insight in Food Safety

  2021cites this paper
• Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents.

  2021cites this paper
• Ancient Roots of Modern Medicines; their Prospects and Promises

  2021cites this paper
• Novel Nitro-Heteroaromatic Antimicrobial Agents for the Control and Eradication of Biofilm-Forming Bacteria

  2021cites this paper
• Scenario planning: An alternative approach to European Commission for combating antimicrobial resistance by 2050

  2021cites this paper
• Pressure response of carbapenems Klebsiella pneumoniae under antibiotic stress.

  2021cites this paper
• 2-Methoxy-5-(6-methoxypyridin-3-yl-imino-methyl)phenol and its transition metal complexes as potent antibacterial agents: Synthesis, characterization, theoretical investigations and biological evaluation

  2021cites this paper
• The Distribution and Antibacterial Activity of Marine Sponge-Associated Bacteria in the Aegean Sea and the Sea of Marmara, Turkey

  2021cites this paper
• Fighting the Rising Spectre of Tough Bugs in Tough Clinical Scenario: A Ten Year Experience from a Hemato-Oncology Centre in Tertiary Health Care Facility in North India

  2021cites this paper
• A Review of Antimicrobial Resistance (AMR) of Escherichia coli on Livestock and Animal Products: Public Health Importance

  2020cites this paper
• Antimicrobial activity of bacteria from marine sponge Suberea mollis and bioactive metabolites of Vibrio sp. EA348

  2020cites this paper
• The study of the antimicrobial susceptibility of the swine erysipelas causative agent strains and isolates to antibiotics

  2020cites this paper
• Synthesis, characterization and antibacterial activity of 1‐([6‐bromo‐2‐hydroxy‐naphthalen‐1‐yl]arylphenyl)methyl)‐3‐chloro‐4‐(arylphenyl)‐azetidin‐2‐one

  2020cites this paper
• Use of antimicrobials in food animals and impact of transmission of antimicrobial resistance on humans

  2020cites this paper
• Streptogramins for the treatment of infections caused by Gram-positive pathogens

  2020cites this paper
• Novel heterocyclic hybrids of pyrazole targeting dihydrofolate reductase: design, biological evaluation and in silico studies

  2020influential citation
• Novel pyranopyrazole derivatives comprising a benzoxazole core as antimicrobial inhibitors: Design, synthesis, microbial resistance and machine aided results.

  2020cites this paper
• Isolation and identification of new antibacterial compounds from Bacillus pumilus

  2019cites this paper
• Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing acetamine phenyl linker.

  2019cites this paper
• Synthesis, resolution, derivatization and antibacterial activity of chuangxinmycin.

  2019cites this paper
• Impediments to Discovery of New Antimicrobials with New Modes of Action

  2019cites this paper
• Nanotechnology: A Twenty-First-Century Approach Towards the Control of Antibiotic-Resistant Bacteria

  2019cites this paper
• Exploration of the structure–activity relationship and druggability of novel oxazolidinone‐based compounds as Gram‐negative antibacterial agents

  2019cites this paper
• Design, synthesis and antibacterial evaluation of 2,4-disubstituted-6-thiophenyl-pyrimidines.

  2019cites this paper
• Efeito de antibiótico vetorizado com nanopartículas magnéticas para tratamento da infecção por Staphylococcus aureus multirresistente

  2019cites this paper
• Novel phthalimide based analogues: design, synthesis, biological evaluation, and molecular docking studies

  2019cites this paper
• N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.

  2018cites this paper
• Design, synthesis and structure-activity relationship evaluation of novel LpxC inhibitors as Gram-negative antibacterial agents.

  2018cites this paper
• Application of Nanoparticle Technologies in the Combat against Anti-Microbial Resistance

  2018cites this paper
• Synthesis and antibacterial activities of novel pleuromutilin derivatives bearing an aminothiophenol moiety

  2018cites this paper
• Antibacterial activity of 3-methylbenzo[d]thiazol-methylquinolinium derivatives and study of their action mechanism

  2018cites this paper
• Genomics driven approach for identification of novel therapeutic targets in Salmonella enterica.

  2018cites this paper
• Clinical impact of antimicrobial resistance in European hospitals: Excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins

  2018cites this paper
• Crystal structures and biochemical characterization of DNA sliding clamps from three Gram-negative bacterial pathogens.

  2018cites this paper
• Society for Translational Medicine expert consensus on the use of antibacterial drugs in thoracic surgery.

  2018cites this paper
• Catalytic Static Mixers for the Continuous Flow Hydrogenation of a Key Intermediate of Linezolid (Zyvox)

  2018cites this paper
• The research of antimicrobial properties of complex antibiotic preparation

  2018cites this paper
• Study of synergy effect of benzalconium chloride on antimicrobial activity of vegetable essential oils

  2018cites this paper
• New application of tiplaxtinin as an effective FtsZ-targeting chemotype for an antimicrobial study.

  2017cites this paper
• Identification and Antibacterial Activity of Bacteria Isolated from Marine Sponge Haliclona (Reniera) sp. against Multi-Drug Resistant Human Pathogen

  2017cites this paper
• A Thiazole Orange Derivative Targeting the Bacterial Protein FtsZ Shows Potent Antibacterial Activity

  2017cites this paper
• Ligand Binding Studies Of A Peptide Targeting Helix 69 Of 23s Rrna In Bacterial Ribosomes

  2017cites this paper
• Determination of antibacterial propertiesof triazines in regards to Salmonella typhimurium

  2017cites this paper
• Drug design based on pentaerythritol tetranitrate reductase: synthesis and antibacterial activity of Pogostone derivatives.

  2017cites this paper
• Structure-activity relationships and molecular docking studies of chromene and chromene based azo chromophores: A novel series of potent antimicrobial and anticancer agents

  2017cites this paper
• Antibacterial activity of N-methylbenzofuro[3,2-b]quinoline and N-methylbenzoindolo[3,2-b]-quinoline derivatives and study of their mode of action.

  2017cites this paper
• Sulfonamide-based non-alkyne LpxC inhibitors as Gram-negative antibacterial agents.

  2017cites this paper
• Functional characterisation of Burkholderia pseudomallei biotin protein ligase: A toolkit for anti-melioidosis drug development.

  2017cites this paper
• A Review on Antibiotic Resistance: Alarm Bells are Ringing

  2017cites this paper
• The Discovery and Development of Drug Combinations for the Treatment of Various Diseases from Patent Literature (1980-Present).

  2017cites this paper
• Suppressive drug combinations and their potential to combat antibiotic resistance

  2017cites this paper
• The current state and development of perspectives of application of synthetic antimicrobial agents

  2017cites this paper
• Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana)

  2016cites this paper
• Thioridazine inhibits gene expression control of the cell wall signaling pathway (CWI) in the human pathogenic fungus Paracoccidioidesbrasiliensis

  2016cites this paper
• Research and development of antibiotics: insights from patents and citation network

  2016cites this paper
• A New Antibiotic Adjuvant Entity (Ceftriaxone + Sulbactam + Disodium Edetate): An Alternative to Carbapenems for the Management of Intensive Care Unit Infection

  2016cites this paper
• A New Fixed Dose Combination of Ceftriaxone + Sulbactam + Disodium Edetate for Definitive Treatment of Infections Due to Piperacillin/ Tazobactam Resistant Bacteria: A Retrospective Efficacy and Pharmacoeconomic Study

  2016cites this paper
• Echinoderms: A Review of Bioactive Compounds With Potential Health Effects

  2016cites this paper
• Is olation, phylogenetic diversity and screening of bioprospecting potentials of ascidians - associated bacteria from Gulf of Mannar, Southeast coast of India

  2016cites this paper
• Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications

  2016cites this paper
• Molecular Docking, Synthesis and Evaluation of Pyrrolo[2,1- c][1,4]benzodiazepines Derivatives as Non-beta-lactam beta-lactamases Inhibitors

  2016cites this paper
• PLA and PLGA nanoarchitectonics for improving anti-infective drugs efficiency

  2016cites this paper
• Tubastraea coccinea: A Non-Indigenous Coral (Cnidaria, Scleractinia) Collected at Arvoredo Island, South of Brazil with Potential MRSA and VRE Antimicrobial Activity

  2016cites this paper
• Synthesis, characterization, molecular modeling, and potential antimicrobial and anticancer activities of novel 2-aminoisoindoline-1,3-dione derivatives.

  2016cites this paper
• Synthesis and Antimicrobial Evaluation of Amixicile-Based Inhibitors of the Pyruvate-Ferredoxin Oxidoreductases of Anaerobic Bacteria and Epsilonproteobacteria

  2016cites this paper
• LpxC Inhibitors: Design, Synthesis, and Biological Evaluation of Oxazolidinones as Gram-negative Antibacterial Agents.

  2016cites this paper
• Identification and characterization of antibacterial compound ( s ) of cockroaches ( Periplaneta americana ) ^ 1

  2016cites this paper
• Evaluation of regional antibiograms to monitor antimicrobial resistance in hampton roads, Virginia

  2015cites this paper
• Vitamin D and respiratory infections.

  2015cites this paper
• Antibacterial Drugs — From Basic Concepts to Complex Therapeutic Mechanisms of Polymer Systems

  2015cites this paper
• Bacterial Sliding Clamp Inhibitors that Mimic the Sequential Binding Mechanism of Endogenous Linear Motifs.

  2015cites this paper
• Investigations on an Innovative Antibiotic Approach : Structure-Function-Analysis of Essential Enzymes Routing the Vitamin B1 de novo Biosynthesis and Vitamin B6 Salvage Pathway of Staphylococcus aureus

  2015cites this paper
• CONTINUOUS VERSUS INTERMITTENT INTRAVENOUS MEROPENEM IN SEVERE SEPSIS

  2015cites this paper
• Review Vitamin D and respiratory infections

  2015cites this paper
• NOVEL ANTIMICROBIAL AGENTS: A REVIEW

  2014cites this paper